Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $65B | +$2.11B | 131 | 1.29% | Increased |
|
| 2 |
BlackRock
New York
| $57.2B | +$326M | 140 | 1.33% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $30.1B | +$258M | 124 | 1.34% | Increased |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $28.6B | +$627M | 107 | 1.92% | Increased |
|
| 5 |
Capital World Investors
Los Angeles,
California
| $16.9B | -$525M | 12 | 2.79% | Reduced |
|
| 6 |
Morgan Stanley
New York
| $16.6B | -$1.06B | 148 | 1.33% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $15.5B | -$180M | 54 | 2.74% | Reduced |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $15.3B | +$139M | 81 | 1.88% | Increased |
|
| 9 |
JP Morgan Chase
New York
| $15.1B | +$932M | 135 | 1.27% | Increased |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $14.5B | +$434M | 148 | 1.34% | Increased |
|
| 11 |
Norges Bank
Oslo,
Norway
| $9B | +$459M | 42 | 1.42% | Increased |
|
| 12 |
Capital International Investors
Los Angeles,
California
| $8.8B | +$41M | 12 | 1.78% | Increased |
|
| 13 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $8.47B | +$448M | 23 | 5.18% | Increased |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $7.97B | +$595M | 134 | 0.72% | Increased |
|
| 15 |
Massachusetts Financial Services
Boston,
Massachusetts
| $7.72B | +$793M | 22 | 2.31% | Increased |
|
| 16 |
Franklin Resources
San Mateo,
California
| $7.43B | +$2.4B | 56 | 2.35% | Increased |
|
| 17 |
Capital Research Global Investors
Los Angeles,
California
| $7.39B | -$339M | 7 | 1.67% | Reduced |
|
| 18 |
Northern Trust
Chicago,
Illinois
| $7.11B | -$265M | 124 | 1.23% | Reduced |
|
| 19 |
Bank of New York Mellon
New York
| $6.74B | -$249M | 89 | 1.29% | Reduced |
|
| 20 |
Janus Henderson Group
London,
| $5.44B | -$335M | 61 | 2.97% | Reduced |
|
| 21 |
Invesco
Atlanta,
Georgia
| $4.79B | +$44.7M | 82 | 1.03% | Increased |
|
| 22 |
Goldman Sachs
New York
| $4.67B | -$193M | 106 | 0.83% | Reduced |
|
| 23 |
Dimensional Fund Advisors
Austin,
Texas
| $4.53B | +$23M | 76 | 1.23% | Increased |
|
| 24 |
Charles Schwab
San Francisco,
California
| $4.45B | +$104M | 96 | 1.03% | Increased |
|
| 25 |
Legal & General Group
London,
United Kingdom
| $4.43B | -$129M | 83 | 1.28% | Reduced |
|